Multi-targeted approach in the treatment of thyroid cancer

References

• American Cancer Society2007Cancer Facts and Figures 2007 Accessed 8 January 2008. URL: http://www.cancer.org/downloads/STT/CAFF2007PWSecured.pdf.
   Google Scholar
• AttieJNKhafifRAStecklerRM1971Elective neck dissection in papillary carcinoma of the thyroidSurgery1116049
   Google Scholar
• BauerD1997Low thyrotropin levels are not associated with bone loss in older women:A prospective studyJ Clin Endocrinol Metab82293159284722
   PubMed Web of Science ®Google Scholar
• BeressiNCamposJMBeressiJP1998Sporadic medullary micro-carcinoma of the thyroid:a retrospective analysis of eighty casesThyroid81039449848720
   PubMed Web of Science ®Google Scholar
• BilimoriaKYBentremDJKoCY2007Extent of surgery affects survival for papillary thyroid cancerAnn Surg2463758117717441
   PubMed Web of Science ®Google Scholar
• BoccaEPignataroOSasakiCT1980Functional neck dissection: a description of operative techniqueArch Otolaryngol10652477406757
   PubMedGoogle Scholar
• BoccaEPignataroOOldiniC1984Functional neck dissection: an evaluation and review of 843 casesLaryngoscope9494256738274
   PubMed Web of Science ®Google Scholar
• BurmeisterLA1994Thyroid hormone in the treatment of thyroid cancerThyroid Today1719
   Google Scholar
• British Thyroid Association and Royal College of PhysiciansGuidelines for the management of thyroid cancer2nd ed Accessed 9 January 2008. URL: http://www.british-thyroid-association.org/Thyroid_cancer_guidelines_2007.pdf.
   Google Scholar
• ByarDPGreenSBSorP1979A prognostic index for thyroid carcinoma:a study of the E.O.R.T.C. Thyroid Cancer Cooperative GroupEur J Cancer15103341510341
   PubMed Web of Science ®Google Scholar
• CadyBSedhwickCEMeissnerWA1979Risk factor analysis in differentiated thyroid cancerCancer4381020427722
   PubMed Web of Science ®Google Scholar
• CarlomagnoFVitaglianoDGuidaT2002ZD6474, an orally available inhibitor of KDR tyrosine kinase activity, efficiently blocks oncogenic RET kinasesCancer Res6272849012499271
   PubMed Web of Science ®Google Scholar
• CheemaYRepplingerDElsonD2006Is tumor size the best predictor of outcome for papillary thyroid cancer?Ann Surg Oncol131524817006742
   PubMed Web of Science ®Google Scholar
• ChenHKunnimalaiyaanMVan GompelJJ2005Medullary thyroid cancer:The functions of raf-1 and human achaetescute homologue-1Thyroid155112116029117
   PubMed Web of Science ®Google Scholar
• ChenHNicolTLUdelsmanR1999Clinically significant, isolated metastatic disease to the thyroid glandWorld J Surg23177809880428
   PubMed Web of Science ®Google Scholar
• ChenHNicolTLZeigerMA1998bHurthle cell neoplasms of the thyroid:Are there factors predictive of malignancy?Ann Surg22754269563543
   PubMed Web of Science ®Google Scholar
• ChenHRobertsJRBallDW1998cEffective long-term palliation of symptomatic, incurable metastatic medullary thyroid cancer by operative resectionAnn Surg227887959637552
   PubMed Web of Science ®Google Scholar
• ChenHUdelsmanR1998Papillary thyroid carcinoma: Justification for total thyroidectomy and management of lymph node metastasesSurg Oncol Clin N Am7645649735127
   PubMedGoogle Scholar
• ChongGCBeahrsOHSizemoreGW1975Medullary carcinoma of the thyroid glandCancer356957041111937
   PubMed Web of Science ®Google Scholar
• ClarkOH1981TSH suppression of thyroid nodules and thyroid cancerWorld J Surg539467233954
   PubMedGoogle Scholar
• ClarkOH1982Total thyroidectomy:The treatment of choice for patients with differentiated thyroid cancerAnn Surg196361707114941
   PubMed Web of Science ®Google Scholar
• ClarkOH1985aEndocrine surgery of the thyroid and parathyroid glandsSt. Louis, MOThe C.V. Mosby Company
   Google Scholar
• ClarkOHGerendPL1985bThyrotropin receptor-adenylate cyclase system in Hurthle cell neoplasmsJ Clin Endocrinol Metab6177382993348
   PubMed Web of Science ®Google Scholar
• CohenPFrameS2001The renaissance of GSK3Nat Rev Mol Cell Bio27697611584304
   PubMed Web of Science ®Google Scholar
• ColonnaMGrandeEJónassonJG2006Variation in relative survival of thyroid cancers in Europe: Results from the analysis on 21 countries over the period 1983–1994 (EUROCARE-3 study)Eur J Cancer42259860816979888
   PubMed Web of Science ®Google Scholar
• CooperDSDohertyGMHaugenBR2006Management guidelines for patients with thyroid nodules and differentiated thyroid cancerThyroid161094216420177
   PubMed Web of Science ®Google Scholar
• DeanDSHayID2000Prognostic indicators in differentiated thyroid carcinomaCancer Control72293910832109
   PubMedGoogle Scholar
• DeGrootLJKaplanELMcCortickM1990Natural history, treatment, and course of papillary thyroid cancerJ Clin Endocrinol Metab71414242380337
   PubMed Web of Science ®Google Scholar
• DurenMSipersteinAEShenW1999Value of stimulated serum thyroglobulin levels for detecting persistent or recurrent differentiated thyroid cancer in high- and low-risk patientsSurgery12613910418587
   PubMed Web of Science ®Google Scholar
• EmerickGTDuhQYSipersteinAE1993Diagnosis, treatment, and outcome of follicular thyroid carcinomaCancer723287958080485
   PubMed Web of Science ®Google Scholar
• FrazellELFooteFW1955Papillary thyroid carcinoma:pathological findsings in cases with and without clinical evidence of cervical node involvementCancer811647013270233
   PubMed Web of Science ®Google Scholar
• FogelfeldLWiviottMBShove-FreedmanE1989Recurrence of thyroid nodules after removal in patients irradiated in childhood for benign conditionsN Engl J Med320835402927450
   PubMed Web of Science ®Google Scholar
• GimmOUkkatJDralleH1999Determinative factors of biochemical cure after primary and reoperative surgery for sporadic medullary thyroid carcinomaWorld J Surg2256279597929
   PubMed Web of Science ®Google Scholar
• GrebeSKHayID1996Thyroid cancer nodal metastases:biologic significance and therapeutic considerationsSurg Oncol Clin N Am543638789493
   PubMedGoogle Scholar
• GreenblattDYElsonDMackE2007Initial lymph node dissection increases cure rates in patients with medullary thyroid cancerAsian J Surg301081217475579
   PubMed Web of Science ®Google Scholar
• HanksJB2004Thyroid MalignanciesTownsendCMBeauchampRDEversBMSabiston Textbook of Surgery17th edPhiladelphiaSaunders96573
   Google Scholar
• HardtSESadoshimaJ2002Glycogen synthase kinase-3β:a novel regulator of cardiac hypertrophy and developmentCirc Res9010556312039794
   PubMed Web of Science ®Google Scholar
• HarwoodAJPlyteSEWoodgettJ1995Glycogen synthase kinase 3 regulates cell fate inDictyostelium Cell8013948
   PubMed Web of Science ®Google Scholar
• HaugenBR1999Management of the patient with progressive radio-iodine non-responsive diseaseSemin Surg Oncol1634419890738
   PubMed Web of Science ®Google Scholar
• HayIDBergstralhEJGoellnerJR1993Predicting outcome in papillary thyroid cancer: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989Surgery114105088256208
   PubMed Web of Science ®Google Scholar
• HayIDGrantCSBergstralhEJ1998Unilateral total lobectomy: Is it sufficient surgical treatment for patients with AMES low-risk papillary thyroid carcinoma?Surgery124958669854569
   PubMed Web of Science ®Google Scholar
• HedingerCWilliamsEDSobinLH1988Histologic typing of thyroid tumorsInternational Histological Classification of Tumors No.11GenevaWorld Health Organization118
   Google Scholar
• HeijckmannACHuijbertsMSGuesensP2005Hip bone mineral density, bone turnover and risk of fracture in patients on long-term suppressive L-thyroxine therapy for differentiated thyroid carcinomaEur J Endocrinol15323915994742
   PubMed Web of Science ®Google Scholar
• HoeltingTSipersteinAEClarkOH1994Epidermal growth factor enhances proliferation, migration, and invasion of follicular and papillary thyroid cancer in vitro and in vivoJ Clin Endocrinol Metab7940188045955
   PubMed Web of Science ®Google Scholar
• HoldenSNEckhardtSGBasserR2005Clinical evaluation of ZD6474, an orally active inhibitor of VEGF and EGF receptor signaling, in patients with solid, malignant tumorsAnn Oncol161391715905307
   PubMed Web of Science ®Google Scholar
• HundahlSAFlemingIDFremgenAM1998A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the US, 1985–1995Cancer832638489874472
   PubMed Web of Science ®Google Scholar
• ItoYMiyauchiA2007Appropriate treatment for asymptomatic papillary microcarcinoma of the thyroidExpert Opin Pharmacother832051518035964
   PubMed Web of Science ®Google Scholar
• ItoYUrunoTNakanaoK2003An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroidThyroid134381712804106
   PubMed Web of Science ®Google Scholar
• KadeschT2004Notch signaling: The demise of elegant simplicityCurr Opin Genet Dev145061215380241
   PubMed Web of Science ®Google Scholar
• KatohRSasakiJKuriharaH1992Multiple thyroid involvement (intraglandular metastases) in papillary thyroid carcinoma. A clinicopathologic study of 105 consecutive patientsCancer701585901516009
   PubMed Web of Science ®Google Scholar
• KebebewEClarkOH2000Medullary thyroid cancerCurr Treat Options Oncol13596712057161
   PubMedGoogle Scholar
• KebebewEWengJBauerJ2007The prevalence and prognostic value of BRAF mutation in thyroid cancerAnn Surg2464667117717450
   PubMed Web of Science ®Google Scholar
• Kendall-TaylorPGuidelines Working Group2003Guidelines for the management of thyroid cancerClin Endocrinol (Oxf)58400212641620
   PubMed Web of Science ®Google Scholar
• KimDWJoYSJungHS2006An orally administered multitarget tyrosine kinase inhibitor, SU11248, is a novel potent inhibitor of thyroid oncogenic RET/papillary thyroid cancer kinasesJ Clin Endocrinol Metab914070616849418
   PubMed Web of Science ®Google Scholar
• KimSYaziciTDCalzadaG2007Sorafenib inhibits the angiogenesis and growth of orthotopic anaplastic thyroid carcinoma xenografts in nude miceMol Cancer Ther617859217575107
   PubMed Web of Science ®Google Scholar
• KimuraETNikiforovaMNZhuZ2003High prevalence of BRAF mutations in thyroid cancer:genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinomaCancer Res631454712670889
   PubMed Web of Science ®Google Scholar
• KrishnamurthyGTBlahdWH1977Radioiodine I131 therapy in the management of thyroid cancer. A prospective studyCancer40195202880551
   PubMed Web of Science ®Google Scholar
• KüçükNOTariPTokmakE2007Treatment for microcarcinoma of the thyroid – clinical experienceClin Nucl Med322798117413573
   PubMed Web of Science ®Google Scholar
• KunnimalaiyaanMChenH2006The Raf-1 pathway:a molecular target for treatment of select neuroendocrine tumors?Anticancer Drugs171394216428931
   PubMed Web of Science ®Google Scholar
• KunnimalaiyaanMChenH2007Tumor suppressor role of Notch-1 signaling in neuroendocrine tumorsOncologist125354217522241
   PubMed Web of Science ®Google Scholar
• KunnimalaiyaanMHaymartMChenH2007aTumor suppressor role of Notch1 and Raf-1 signaling in medullary thyroid cancer cellsTranslational Oncogenomics2437
   PubMedGoogle Scholar
• KunnimalaiyaanMVaccaroAMNdiayeM2006Overexpression of the NOTCH1 intracellular domain inhibits cell proliferation and alters the neuroendocrine phenotype of medullary thyroid cancer cellsJ Biol Chem281398193017090547
   PubMed Web of Science ®Google Scholar
• KunnimalaiyaanMVaccaroAMNdiayeMA2007bInactivation of glycogen synthase kinase-3β, a downstream target of the raf-1 pathway, is associated with growth suppression in medullary thyroid cancer cellsMol Cancer Ther61151817363508
   PubMed Web of Science ®Google Scholar
• LamKYLoCYChanKW2000Insular and anaplastic carcinoma of the thyroid:A 45-year comparative study at a single institution and a review of the significance of p53 and p21Ann Surg2313293810714625
   PubMed Web of Science ®Google Scholar
• LangBHLoCY2007Surgical options in undifferentiated thyroid carcinomaWorld J Surg319697717483987
   PubMed Web of Science ®Google Scholar
• LundgrenCIHallPDickmanPW2006Clincally significant prognostic factors for differentiated thyroid carcinoma:a population-based, nested case-control studyCancer1065243116369995
   PubMed Web of Science ®Google Scholar
• MachensAHolzhausenHJDralleH2004Skip metastases in thyroid cancer leaping the central lymph node compartmentArch Surg13943514718274
   PubMedGoogle Scholar
• MachensAHauptmannSDralleH2007Increased risk of lymph node metastasis in multifocal hereditary and sporadic medullary thyroid cancerWorld J Surg311960517665245
   PubMed Web of Science ®Google Scholar
• MaillardIPearWS2003Notch and cancer:Best to avoid the ups and downsCancer Cell3203512676578
   PubMed Web of Science ®Google Scholar
• MalaguarneraRVellaVVigneriR2007p53 family proteins in thyroid cancerEndocr Relat Cancer14436017395974
   PubMed Web of Science ®Google Scholar
• ManieSSantoroMFuscoA2001The RET receptor:function in development and dysfunction in congenital malformationTrends Genet17580911585664
   PubMed Web of Science ®Google Scholar
• MazzaferriE1988Papillary thyroid carcinoma:factors influencing prognosis and current therapySemin Oncol14315323306936
   PubMed Web of Science ®Google Scholar
• MazzaferriEL1999NCCN thyroid carcinoma practice guidelinesOncology1339142
   Web of Science ®Google Scholar
• MazzaferriEL2007Management of low-risk differentiated thyroid cancerEndocr Pr13498512
   PubMedGoogle Scholar
• MazzaferriELJhiangSM1994Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancerAm J Med97418287977430
   PubMed Web of Science ®Google Scholar
• MazzaferriEYoungRLOertelJE1977Papillary thyroid carcinoma: The impact of therapy in 576 patientsMedicine5617196859443
   PubMed Web of Science ®Google Scholar
• MazzaferriEYoungRL1981Papillary thyroid carcinoma:A 10 year follow-up report of the impact of therapy in 576 patientsAm J Med70551558
   Web of Science ®Google Scholar
• MitsiadesCSKotoulaVPoulakiV2006Epidermal growth factor receptor as a therapeutic target in human thyroid carcinoma:mutational and functional analysisJ Clin Endocrinol Metab913662616822827
   PubMed Web of Science ®Google Scholar
• MorettiFFarsettiASodduS1997p53 re-expression inhibits proliferation and restores differentiation of human thyroid anaplastic carcinoma cellsOncogene14729409038381
   PubMed Web of Science ®Google Scholar
• [NCI] National Cancer Institute Surveillance Epidemiology and End Results Database, US National Institutes of Health URL: http://seer.cancer.gov/statfacts/html/thyro.html; accessed March 28, 2008.
   Google Scholar
• OlivierMEelesRHollsteinM2002The IARC TP53 database: new online mutation analysis and recommendations to usersHum Mutat196071412007217
   PubMed Web of Science ®Google Scholar
• OzataMSuzukiSMiyamotoT1994Serum thyroglobulin in the follow-up of patients with treated differentiated thyroid cancerJ Clin Endocrinol Metab79981058027262
   PubMed Web of Science ®Google Scholar
• PaloyanEWalkerRPLawrenceAM1998Guidelines for the use of radioiodine, thyroid hormone, and treatment of metastatic disease in patients with differentiated thyroid cancerSurg Oncol Clin N Am7665809735128
   PubMedGoogle Scholar
• ParkJIStrockCJBallDW2003The ras/raf/MEK/extracellular signal-regulated kinase pathway induces autocrine-paracrine growth inhibition via the leukemia inhibitory factor/JAK/STAT pathwayMol Cell Biol235435412509453
   PubMed Web of Science ®Google Scholar
• PerrosPThyroid Cancer Guidelines Update Group2007Introduction to the updated guidelines on the management of thyroid cancerClin Med7321217882843
   PubMed Web of Science ®Google Scholar
• PujolPDauresJPNsakalaNDegree of thyrotropin suppression as a prognostic determinant in differentiated thyroid cancerJ Clin Endocrinol Metab814318238954034
   PubMed Web of Science ®Google Scholar
• QubainSWNakanoSBabaM2002Distribution of lymph node micrometastases in pN0 well-differentiated thyroid carcinomaSurgery1312495611894028
   PubMed Web of Science ®Google Scholar
• RaviRKThiagalingamAWeberE1999Raf-1 causes growth suppression and alteration of neuroendocrine markers in DMS53 human small cell lung cancer cellsAm J Respir Cell Mol Biol20543910100985
   PubMed Web of Science ®Google Scholar
• RaviRKWeberEMcMahon1998Activated raf-1 causes growth arrest in human small cell lung cancersJ Clin Invest10115399421477
   PubMed Web of Science ®Google Scholar
• RougierPParmentierCLaplancheA1983Medullary thyroid carcinoma:prognostic factors and treatmentINt J Radiat Oncol Biol Phys91611696833017
   PubMed Web of Science ®Google Scholar
• SaadMFOrdonezNGRashidRK1984Medullary carcinoma of the thyroid:a study of the clinical features and prognostic factors in 161 patientsMedicine (Baltimore)633193426503683
   PubMed Web of Science ®Google Scholar
• SaltmanBSinghBHedvatCV2006Patterns of expression of cell cycle/apoptosis genes along the spectrum of thyroid carcinoma progressionSurgery14089990617188136
   PubMed Web of Science ®Google Scholar
• SalvatoreGDe FalcoVSalernoP2006BRAF is a therapeutic target in aggressive thyroid carcinomaClin Cancer Res121623916533790
   PubMed Web of Science ®Google Scholar
• SandersLECadyB1998Differentiated thyroid cancer:Reexamination of risk groups and outcome of treatmentArch Surg133419259565123
   PubMedGoogle Scholar
• SawkaAMLakraDCLeaJ2008aA systematic review of the gonadal effects of therapeutic radioactive iodine in male thyroid cancer survivorsClin Endocrinol686107
   PubMed Web of Science ®Google Scholar
• SawkaAMLakraDCLeaJ2008bA systematic review examining the effects of therapeutic radioactive iodine on ovarian function and future pregnancy in female thyroid cancer survivorsClin Endocrinol Feb 13 (Epub ahead of print).
   Web of Science ®Google Scholar
• SchneiderABFavusMJStachouraME1978Incidence, prevalence, and characteristics of radiation-induced thyroid tumorsAm J Med6424352629274
   PubMed Web of Science ®Google Scholar
• ScolloCBaudinETravalgiJP2003Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancerJ Clin Endocrinol Metab882070512727956
   PubMed Web of Science ®Google Scholar
• ShahaAR1998Management of the neck in thyroid cancerOtolaryngol Clin North Am31823319735110
   PubMed Web of Science ®Google Scholar
• ShermanSI2003Thyroid carcinomaLancet3615011112583960
   PubMed Web of Science ®Google Scholar
• ShibaEMiyauchiKKobayashiT1989The effect of thyroid hormone on the growth of thyroid cancer [Japanese]Gan To Kagaku Ryoho163678842688557
   PubMedGoogle Scholar
• SilverbergSGHutterRVPFooteFWJr1970Fatal carcinoma of the thyroid: histology, metastases, and causes of deathCancer257928025443103
   PubMed Web of Science ®Google Scholar
• SimonDGoretzkiPEWitteJ1996Incidence of regional recurrence guiding radicality in differentiated thyroid carcinomaWorld J Surg2086068678963
   PubMed Web of Science ®Google Scholar
• SippelRSCarpenterJEKunnimalaiyaanM2003The role of human achaete-scute homolog-1 in medullary thyroid cancer cellsSurgery1348667114668716
   PubMed Web of Science ®Google Scholar
• SolansRBoschJAGalofréP2001Salivary and lacrimal gland dysfunction (sicca syndrome) after radioiodine therapyJ Nucl Med427384311337569
   PubMed Web of Science ®Google Scholar
• SuginoKItoKMimuraT2002The important role of operations in the management of anaplastic carcinomaSurgery131245811894027
   PubMed Web of Science ®Google Scholar
• SywakMCornfordLRoachP2006Routine ipsilateral level VI lymphadenopathy reduces postoperative thyroglobulin levels in papillary thyroid cancerSurgery1401000717188149
   PubMed Web of Science ®Google Scholar
• TamuraTMinamiHYamadaY2006A Phase I dose-escalation study of ZD6474 in Japanese patients with solid, malignant tumorsJ Thorac Oncol11002917409986
   PubMed Web of Science ®Google Scholar
• Task ForceTC2001AACE/AAES medical/surgical guidelines for clinical practice:Management of thyroid carcinomaEndocr Pr720320
   Google Scholar
• TaylorTSpeckerBRobbinsJ1989Outcome after treatment of high-risk papillary and non-Hürthle-cell follicular thyroid carcinomaAnn Int Med12962279786809
   PubMed Web of Science ®Google Scholar
• TennvallJLundellGHallquistA1994Combined doxorubicin, hyperfractionated radiotherapy, and surgery in anaplastic thyroid carcinomaCancer741348548055459
   PubMed Web of Science ®Google Scholar
• Thyroid Carcinoma Task Force2001AACE/AAES medical/surgical guidelines for clinical practice:management of thyroid carcinoma. American Association of Clinical Endocrinologists. American College of EndocrinologyEndocr Pract72022011430305
   PubMedGoogle Scholar
• TroviscoVSoaresPSobrinho-SimoesM2006B-RAF mutations in the etiopathogenesis, diagnosis, and prognosis of thyroid carcinomasHum Pathol37781616784975
   PubMed Web of Science ®Google Scholar
• UdelsmanRChenH1999The current management of thyroid cancerAdv Surg3312710572560
   PubMedGoogle Scholar
• VaccaroAChenHKunnimalaiyaanM2006In-vivo activation of Raf-1 inhibits tumor growth and development in a xenograft model of human medullary thyroid cancerAnticancer Drugs178495316926634
   PubMed Web of Science ®Google Scholar
• VidalMWellsSRyanA2005ZD6474 suppresses oncogenic RET isoforms in a Drosphila model for type 2 multiple endocrine neo-plasia syndromes and papillary thyroid carcinomaCancer Res6535384115867345
   PubMed Web of Science ®Google Scholar
• WedgeSROgilvieDJDukesM2002ZD6474 inhibits vascular endothelial growth factor signaling, angiongenesis, and tumor growth following oral administrationCancer Res6246455512183421
   PubMed Web of Science ®Google Scholar
• WellsSGosnellJGagelRF2007Vandetanib in metastatic hereditary medullary thyroid cancer:follow-up results of an open-label phase II trial [abstract]Proc Am Soc Clin Oncol Abst 6018.
   Web of Science ®Google Scholar
• WhiteMLGaugerPGDohertyG2007Central lymph node dissection in differentiated thyroid cancerWorld J Surg3189590417347896
   PubMed Web of Science ®Google Scholar
• WongJBKaplanMMMeyerKB1990Ablative radioactive iodine therapy for apparently localized thyroid carcinoma:a decision analytic perspectiveEndocrinol Metab Clin North Am19741602261914
   PubMed Web of Science ®Google Scholar
• XingM2005BRAF mutation in thyroid cancerEndocr-Relat Cancer122456215947100
   PubMed Web of Science ®Google Scholar
• YehMWRougierJPParkJW2006Differentiated thyroid cancer cell invasion is regulated through epidermal growth factor receptor-dependent activation of matrix metalloproteinase (MMP)-2/gelatinase AEndocr-Relat Cancer1311738317158762
   PubMed Web of Science ®Google Scholar
• YoonKGaianoN2005Notch signaling in the mammalian central nervous system:Insights from mouse mutantsNat Neurosci87091515917835
   PubMed Web of Science ®Google Scholar
• YoungRLMazzaferriELRaheAJ1980Pure follicular thyroid carcinoma:impact of therapy in 214 patientsJ Nuclear Med217337
   PubMed Web of Science ®Google Scholar
• YutanEClarkOH2001Hürthle cell carcinomaCurr Treat Options Oncol2331512057113
   PubMedGoogle Scholar